Zevra Therapeutics Inc. (ZVRA)
$8.84 -$0.09 (-1.01%) 4:38 PM 12/11/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$488.39M -
Day's Range
$8.64 - $8.92 -
Volume
427,340 -
52 Week Low / High
$4.20 - $9.76 -
PE Ratio
- -
PEG Ratio
10.67 -
Dividend Frequency
-
ZVRA's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 4
- Strong Buy
- 4
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong Sell
- $19.25
- Target Price
Company News
-
Zevra Therapeutics' Drug Becomes First FDA-Approved Treatment For Ultra-Rare Neurodegenerative Disease — Sep 20th, 2024
Zevra Therapeutics' Drug Becomes First FDA-Approved Treatment For Ultra-Rare Neurodegenerative Disease Friday, the FDA approved Zevra Therapeutics, Inc.'s (NASDAQ:ZVRA) Miplyffa (arimoclomol), an oral medication for Neimann-Pick disease, type C (NPC). Miplyffa, in combination with John...
Similar Stocks
No similar stocks found.
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$